| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Beone Medicines AG's insiders have reduced their positions by a net 31,028 shares worth roughly $11.3M. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
ONC sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 397.9K | - | - | |
| Dir | 161.6K | - | - | |
| Other | 99.6K | $25.66M | - | |
| Dir | 83.7K | - | - | |
| Dir | 73.2K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 27, 2026 | Wang Xiaodong58 | Director, Chair, Scientific Advisory Brd | Sale+OE10b5-1 | 31,028 | $362.97 | $11,262,131.06 | - | - | - | |
| Jun 23, 2026 | Oyler John58 | Chief Executive Officer | Sell | 3,410 | $273.78 | $933,592.21 | -100% | +32.4% | - | |
| Jun 23, 2026 | Wang Lai50 | President, Global Head of R&D | Sell | 1,068 | $276.74 | $295,552.98 | -100% | +32.4% | - | |
| Jun 23, 2026 | Wu Xiaobin52 | President and COO | Sell | 1,292 | $276.26 | $356,926.89 | -100% | +32.4% | - | |
| Jun 16, 2026 | Wu Xiaobin52 | President and COO | Sell | 1,357 | $266.76 | $361,996.85 | -100% | +34.1% | - | |
| Jun 16, 2026 | Oyler John58 | Chief Executive Officer | Sell | 3,693 | $265.55 | $980,686.48 | -100% | +34.1% | - | |
| Jun 16, 2026 | Lee Chan Henry49 | SVP, General Counsel | Sell | 590 | $265.98 | $156,925.25 | -100% | +34.1% | - | |
| Jun 16, 2026 | Wang Lai50 | President, Global Head of R&D | Sell | 1,169 | $265.39 | $310,235.88 | -100% | +34.1% | - | |
| Jun 11, 2026 | Oyler John58 | Chief Executive Officer | Sell | 1,949 | $257.24 | $501,354.72 | -100% | +34.9% | - | |
| Jun 11, 2026 | Ball Titus B. | Principal Accounting Officer | Sell | 169 | $257.20 | $43,466.56 | -100% | +34.9% | - |